-
1 Comment
Genix Pharmaceuticals Corporation is currently in a long term uptrend where the price is trading 9.7% above its 200 day moving average.
From a valuation standpoint, the stock is 462.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 5737.4.
Genix Pharmaceuticals Corporation's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 1390.7% to $-563K since the same quarter in the previous year.
Finally, its free cash flow fell by 263.2% to $-165K since the same quarter in the previous year.
Based on the above factors, Genix Pharmaceuticals Corporation gets an overall score of 1/5.
ISIN | CA37232A1093 |
---|---|
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Exchange | V |
CurrencyCode | CAD |
Beta | 0.45 |
---|---|
Target Price | None |
Market Cap | 2M |
PE Ratio | 0.0 |
Dividend Yield | None |
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to support kidney health; and Sucanon, a herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. The company was incorporated in 1993 and is based in Vancouver, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for GENX.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025